Genmab A/S (GMAB)
USD 20.07
(0.15%)
USD 20.07
(0.15%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 10.92 Billion DKK | 28.67% |
| 2022 | 8.23 Billion DKK | 50.77% |
| 2021 | 5.46 Billion DKK | 43.87% |
| 2020 | 3.79 Billion DKK | 39.22% |
| 2019 | 2.72 Billion DKK | 65.85% |
| 2018 | 1.64 Billion DKK | 61.06% |
| 2017 | 1.02 Billion DKK | 33.8% |
| 2016 | 763.28 Million DKK | 89.56% |
| 2015 | 402.66 Million DKK | -31.19% |
| 2014 | 585.2 Million DKK | -1.53% |
| 2013 | 594.31 Million DKK | -1.16% |
| 2012 | 601.31 Million DKK | 786.23% |
| 2011 | 67.85 Million DKK | -57.66% |
| 2010 | 160.25 Million DKK | -85.22% |
| 2009 | 1.08 Billion DKK | -19.4% |
| 2008 | 1.34 Billion DKK | 39.15% |
| 2007 | 966.67 Million DKK | 59.05% |
| 2006 | 607.76 Million DKK | 15.45% |
| 2005 | 526.42 Million DKK | 220.42% |
| 2004 | -437.17 Million DKK | -206.49% |
| 2003 | 410.53 Million DKK | -6.73% |
| 2002 | 440.17 Million DKK | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 3.15 Billion DKK | 9.54% |
| 2024 Q2 | 3.39 Billion DKK | 7.57% |
| 2023 Q4 | 2.88 Billion DKK | -1.54% |
| 2023 Q1 | 2.41 Billion DKK | -5.66% |
| 2023 FY | 10.6 Billion DKK | 28.67% |
| 2023 Q2 | 2.7 Billion DKK | 11.75% |
| 2023 Q3 | 2.92 Billion DKK | 8.37% |
| 2022 FY | 8.23 Billion DKK | 50.77% |
| 2022 Q4 | 2.56 Billion DKK | 18.83% |
| 2022 Q1 | 1.6 Billion DKK | -11.33% |
| 2022 Q2 | 1.91 Billion DKK | 19.31% |
| 2022 Q3 | 2.15 Billion DKK | 12.58% |
| 2021 FY | 5.46 Billion DKK | 43.87% |
| 2021 Q1 | 1.04 Billion DKK | -9.33% |
| 2021 Q3 | 1.42 Billion DKK | 19.83% |
| 2021 Q4 | 1.81 Billion DKK | 27.46% |
| 2021 Q2 | 1.18 Billion DKK | 12.96% |
| 2020 Q3 | 866 Million DKK | -9.22% |
| 2020 FY | 3.79 Billion DKK | 39.22% |
| 2020 Q1 | 821 Million DKK | 4.56% |
| 2020 Q2 | 954 Million DKK | 16.2% |
| 2020 Q4 | 1.15 Billion DKK | 33.6% |
| 2019 Q2 | 636.74 Million DKK | 3.21% |
| 2019 FY | 2.72 Billion DKK | 65.85% |
| 2019 Q4 | 785.2 Million DKK | 13.95% |
| 2019 Q3 | 689.11 Million DKK | 8.22% |
| 2019 Q1 | 616.93 Million DKK | 19.83% |
| 2018 Q3 | 398.42 Million DKK | 6.35% |
| 2018 Q4 | 514.83 Million DKK | 29.22% |
| 2018 Q1 | 356.96 Million DKK | 13.51% |
| 2018 FY | 1.64 Billion DKK | 61.06% |
| 2018 Q2 | 374.63 Million DKK | 4.95% |
| 2017 FY | 1.02 Billion DKK | 33.8% |
| 2017 Q4 | 314.47 Million DKK | 18.6% |
| 2017 Q3 | 265.14 Million DKK | 11.91% |
| 2017 Q2 | 236.93 Million DKK | 15.74% |
| 2017 Q1 | 204.7 Million DKK | -6.77% |
| 2016 Q1 | 153.83 Million DKK | -22.82% |
| 2016 FY | 763.28 Million DKK | 89.56% |
| 2016 Q3 | 177.82 Million DKK | -16.14% |
| 2016 Q2 | 212.04 Million DKK | 37.84% |
| 2016 Q4 | 219.58 Million DKK | 23.48% |
| 2015 FY | 402.66 Million DKK | -31.19% |
| 2015 Q1 | -66.16 Million DKK | -142.8% |
| 2015 Q4 | 199.31 Million DKK | 47.54% |
| 2015 Q3 | 135.08 Million DKK | 0.49% |
| 2015 Q2 | 134.42 Million DKK | 303.18% |
| 2014 Q4 | 154.58 Million DKK | 16.94% |
| 2014 FY | 585.2 Million DKK | -1.53% |
| 2014 Q3 | 132.19 Million DKK | -10.49% |
| 2014 Q2 | 147.69 Million DKK | -2.01% |
| 2014 Q1 | 150.72 Million DKK | -7.38% |
| 2013 Q1 | 130.66 Million DKK | -23.58% |
| 2013 FY | 594.31 Million DKK | -1.16% |
| 2013 Q4 | 162.72 Million DKK | 12.25% |
| 2013 Q3 | 144.96 Million DKK | -7.05% |
| 2013 Q2 | 155.95 Million DKK | 19.35% |
| 2012 Q4 | 170.99 Million DKK | 19.47% |
| 2012 Q3 | 143.13 Million DKK | 782.01% |
| 2012 Q2 | 16.22 Million DKK | 7.44% |
| 2012 Q1 | 15.1 Million DKK | -0.73% |
| 2012 FY | 601.31 Million DKK | 786.23% |
| 2011 Q2 | 17.76 Million DKK | 2.26% |
| 2011 Q1 | 17.37 Million DKK | -42.3% |
| 2011 Q3 | 17.49 Million DKK | -1.55% |
| 2011 Q4 | 15.21 Million DKK | -13.02% |
| 2011 FY | 67.85 Million DKK | -57.66% |
| 2010 Q3 | 26.77 Million DKK | -89.84% |
| 2010 Q1 | 253.02 Million DKK | -73.89% |
| 2010 Q4 | 30.11 Million DKK | 12.49% |
| 2010 Q2 | 263.6 Million DKK | 4.18% |
| 2010 FY | 160.25 Million DKK | -85.22% |
| 2009 Q4 | 969.17 Million DKK | 2302.56% |
| 2009 FY | 1.08 Billion DKK | -19.4% |
| 2009 Q2 | 250.49 Million DKK | -12.61% |
| 2009 Q1 | 286.63 Million DKK | 0.0% |
| 2009 Q3 | 40.33 Million DKK | -83.9% |
| 2008 FY | 1.34 Billion DKK | 39.15% |
| 2007 FY | 966.67 Million DKK | 59.05% |
| 2006 FY | 607.76 Million DKK | 15.45% |
| 2005 FY | 526.42 Million DKK | 220.42% |
| 2004 FY | -437.17 Million DKK | -206.49% |
| 2003 FY | 410.53 Million DKK | -6.73% |
| 2002 FY | 440.17 Million DKK | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Agenus Inc. | 78.18 Million USD | -13876.184% |
| Xeris Biopharma Holdings, Inc. | 168.43 Million USD | -6387.33% |
| Verrica Pharmaceuticals Inc. | 70.59 Million USD | -15378.653% |
| Sorrento Therapeutics, Inc. | 403.56 Million USD | -2607.632% |
| Viracta Therapeutics, Inc. | 50.69 Million USD | -21455.244% |
| ChromaDex Corporation | 56.37 Million USD | -19281.33% |
| Pharming Group N.V. | 225.49 Million USD | -4745.87% |
| Psyence Biomedical Ltd. | 2.75 Million USD | -397016.571% |
| CARGO Therapeutics, Inc. Common Stock | 96.71 Million USD | -11198.728% |
| Telomir Pharmaceuticals, Inc. Common Stock | 3.94 Million USD | -277090.942% |
| SELLAS Life Sciences Group, Inc. | 37.86 Million USD | -28754.736% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -44854.853% |
| Aadi Bioscience, Inc. | 93.47 Million USD | -11589.381% |
| AbCellera Biologics Inc. | 275.23 Million USD | -3870.105% |
| Akebia Therapeutics, Inc. | 201.11 Million USD | -5333.21% |
| Alkermes plc | 996.24 Million USD | -996.817% |
| Alnylam Pharmaceuticals, Inc. | 1.8 Billion USD | -507.035% |
| AlloVir, Inc. | 180.93 Million USD | -5939.252% |
| AnaptysBio, Inc. | 181.56 Million USD | -5918.131% |
| Aptorum Group Limited | 10.56 Thousand USD | -103416519.345% |
| Ardelyx, Inc. | 169.93 Million USD | -6330.03% |
| Arrowhead Pharmaceuticals, Inc. | 445.73 Million USD | -2351.446% |
| Opthea Limited | 191.96 Million USD | -5592.112% |
| Bicycle Therapeutics plc | 216.92 Million USD | -4937.295% |
| Barinthus Biotherapeutics plc | 84.71 Million USD | -12798.39% |
| C4 Therapeutics, Inc. | 159.78 Million USD | -6738.479% |
| Avidity Biosciences, Inc. | 245.15 Million USD | -4357.126% |
| Clearside Biomedical, Inc. | 32.71 Million USD | -33300.581% |
| Chimerix, Inc. | 93.38 Million USD | -11600.521% |
| Corbus Pharmaceuticals Holdings, Inc. | 13.9 Million USD | -78457.024% |
| Dyadic International, Inc. | 9.15 Million USD | -119285.589% |
| Elevation Oncology, Inc. | 45.44 Million USD | -23944.449% |
| ESSA Pharma Inc. | 32.13 Million USD | -33904.371% |
| Fate Therapeutics, Inc. | 254.04 Million USD | -4201.223% |
| Fortress Biotech, Inc. | 200.19 Million USD | -5358.178% |
| Fortress Biotech, Inc. | 200.19 Million USD | -5358.178% |
| GlycoMimetics, Inc. | 39.28 Million USD | -27714.48% |
| Structure Therapeutics Inc. | 102.77 Million USD | -10531.963% |
| HOOKIPA Pharma Inc. | 32.74 Million USD | -33268.961% |
| Hoth Therapeutics, Inc. | 7.69 Million USD | -141952.213% |
| IDEAYA Biosciences, Inc. | 157.81 Million USD | -6823.974% |
| Inhibikase Therapeutics, Inc. | 6.73 Million USD | -162215.67% |
| Innoviva, Inc. | 132.15 Million USD | -8168.384% |
| IO Biotech, Inc. | 91.44 Million USD | -11849.52% |
| Keros Therapeutics, Inc. | 169.27 Million USD | -6355.1% |
| Longboard Pharmaceuticals, Inc. | 56.75 Million USD | -19151.572% |
| Ligand Pharmaceuticals Incorporated | 84.32 Million USD | -12858.505% |
| ContextLogic Inc. | 387 Million USD | -2723.514% |
| Lantern Pharma Inc. | 17.87 Million USD | -61021.282% |
| Madrigal Pharmaceuticals, Inc. | 380.49 Million USD | -2771.778% |
| MiMedx Group, Inc. | 229.72 Million USD | -4656.515% |
| Marinus Pharmaceuticals, Inc. | 160.54 Million USD | -6706.403% |
| Ocuphire Pharma, Inc. | 29.6 Million USD | -36808.059% |
| Onconetix, Inc. | 34.9 Million USD | -31202.791% |
| Oncternal Therapeutics, Inc. | 12.74 Million USD | -85628.856% |
| Outlook Therapeutics, Inc. | 53.12 Million USD | -20467.936% |
| Vaxcyte, Inc. | 468.04 Million USD | -2234.625% |
| PDS Biotechnology Corporation | 43.04 Million USD | -25284.924% |
| Precigen, Inc. | 84.18 Million USD | -12880.364% |
| Phathom Pharmaceuticals, Inc. | 167.82 Million USD | -6410.871% |
| Pieris Pharmaceuticals, Inc. | 72.56 Million USD | -14958.016% |
| Pyxis Oncology, Inc. | 82.19 Million USD | -13193.834% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -44854.853% |
| Sangamo Therapeutics, Inc. | 228.68 Million USD | -4678.293% |
| Sol-Gel Technologies Ltd. | 30.85 Million USD | -35309.443% |
| Acelyrin, Inc. | 422.06 Million USD | -2488.944% |
| Sensei Biotherapeutics, Inc. | 37.06 Million USD | -29381.438% |
| Senti Biosciences, Inc. | 94.7 Million USD | -11437.934% |
| Stoke Therapeutics, Inc. | 123.55 Million USD | -8743.978% |
| Alaunos Therapeutics, Inc. | 29.46 Million USD | -36979.643% |
| Entrada Therapeutics, Inc. | 132.17 Million USD | -8167.07% |
| VYNE Therapeutics Inc. | 29.68 Million USD | -36713.557% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -62493.802% |
| Wave Life Sciences Ltd. | 181.3 Million USD | -5926.994% |
| Molecular Templates, Inc. | 63.09 Million USD | -17219.427% |
| Scopus BioPharma Inc. | 11.71 Million USD | -93174.56% |
| BioXcel Therapeutics, Inc. | 171.9 Million USD | -6256.529% |
| Caribou Biosciences, Inc. | 150.53 Million USD | -7158.729% |
| Eton Pharmaceuticals, Inc. | 22.25 Million USD | -49003.492% |
| Geron Corporation | 70.44 Million USD | -15412.273% |
| Inhibrx Biosciences, Inc. | 219.83 Million USD | -4870.659% |
| Incyte Corporation | 1.19 Billion USD | -817.853% |
| Intensity Therapeutics, Inc. | 8.31 Million USD | -131249.922% |
| Jaguar Health, Inc. | 42.01 Million USD | -25907.378% |
| Kintara Therapeutics, Inc. | 8.45 Million USD | -129198.308% |
| MEI Pharma, Inc. | 34.78 Million USD | -31312.965% |
| Novavax, Inc. | 779.12 Million USD | -1302.471% |
| NextCure, Inc. | 67.63 Million USD | -16055.359% |
| PureTech Health plc | 144.59 Million USD | -7456.865% |
| Rigel Pharmaceuticals, Inc. | 130.26 Million USD | -8288.414% |
| TransCode Therapeutics, Inc. | 19.41 Million USD | -56171.035% |
| Seer, Inc. | 110.49 Million USD | -9789.583% |
| Salarius Pharmaceuticals, Inc. | 12.89 Thousand USD | -84744742.562% |
| Summit Therapeutics Inc. | 87.68 Million USD | -12361.51% |
| Syndax Pharmaceuticals, Inc. | 229.95 Million USD | -4651.82% |
| Syros Pharmaceuticals, Inc. | 30.77 Million USD | -35410.708% |
| VistaGen Therapeutics, Inc. | 34.08 Million USD | -31958.09% |
| eFFECTOR Therapeutics, Inc. | 33.84 Million USD | -32186.373% |
| TRACON Pharmaceuticals, Inc. | 18.92 Million USD | -57626.24% |
| Orchestra BioMed Holdings, Inc. | 54.08 Million USD | -20105.251% |
| Vaxxinity, Inc. | 56.05 Million USD | -19394.746% |
| ADMA Biologics, Inc. | 66.58 Million USD | -16310.357% |
| Alzamend Neuro, Inc. | 9.93 Million USD | -109855.628% |
| Compass Therapeutics, Inc. | 48.47 Million USD | -22442.446% |
| Catalyst Pharmaceuticals, Inc. | 259.42 Million USD | -4112.007% |
| CRISPR Therapeutics AG | 463.49 Million USD | -2257.528% |
| Precision BioSciences, Inc. | 92.46 Million USD | -11717.7% |
| GT Biopharma, Inc. | 13.57 Million USD | -80387.625% |
| ImmuCell Corporation | 9.61 Million USD | -113517.435% |
| Immix Biopharma, Inc. | 16.14 Million USD | -67596.695% |
| Janux Therapeutics, Inc. | 81.06 Million USD | -13379.806% |
| Mesoblast Limited | 5.9 Million USD | -185040.63% |
| Rocket Pharmaceuticals, Inc. | 259.65 Million USD | -4108.212% |
| Aptose Biosciences Inc. | 52.35 Million USD | -20770.578% |
| ZyVersa Therapeutics, Inc. | 14.41 Million USD | -75727.317% |
| Soligenix, Inc. | 7.79 Million USD | -140075.089% |
| Century Therapeutics, Inc. | 56.07 Million USD | -19387.792% |
| Kura Oncology, Inc. | 165.8 Million USD | -6490.311% |
| TScan Therapeutics, Inc. | 114.5 Million USD | -9442.648% |
| Ocean Biomedical, Inc. | 2.48 Million USD | -440213.841% |
| CytomX Therapeutics, Inc. | 107.69 Million USD | -10045.964% |
| Autolus Therapeutics plc | 196.72 Million USD | -5454.426% |
| Mineralys Therapeutics, Inc. | 84.65 Million USD | -12807.379% |
| EyePoint Pharmaceuticals, Inc. | 116.45 Million USD | -9283.185% |
| Eterna Therapeutics Inc. | 19.38 Million USD | -56274.142% |
| Adaptive Biotechnologies Corporation | 321.75 Million USD | -3296.031% |
| GRI Bio, Inc. | 11.33 Million USD | -96343.071% |
| Xenetic Biosciences, Inc. | 7.05 Million USD | -154767.674% |
| Tenaya Therapeutics, Inc. | 131.19 Million USD | -8228.95% |
| IGM Biosciences, Inc. | 265.59 Million USD | -4014.221% |
| INmune Bio, Inc. | 29.89 Million USD | -36450.04% |
| Heron Therapeutics, Inc. | 172.55 Million USD | -6232.51% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -27004.519% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -68281.958% |
| Entero Therapeutics, Inc. | 15.74 Million USD | -69315.006% |
| Milestone Pharmaceuticals Inc. | 62.09 Million USD | -17496.38% |
| X4 Pharmaceuticals, Inc. | 107.52 Million USD | -10062.571% |
| Atara Biotherapeutics, Inc. | 275.69 Million USD | -3863.467% |
| Coherus BioSciences, Inc. | 301.45 Million USD | -3524.801% |
| Verastem, Inc. | 92.08 Million USD | -11766.339% |
| Abeona Therapeutics Inc. | 17.93 Million USD | -60811.976% |
| Pliant Therapeutics, Inc. | 185.72 Million USD | -5783.43% |
| Tonix Pharmaceuticals Holding Corp. | 121.4 Million USD | -8900.305% |
| Histogen Inc. | 14.27 Million USD | -76462.5% |
| Aprea Therapeutics, Inc. | 16.04 Million USD | -67988.879% |
| Surrozen, Inc. | 18.55 Million USD | -58805.66% |
| Organovo Holdings, Inc. | 14.91 Million USD | -73161.817% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -214565.882% |
| Ovid Therapeutics Inc. | 59.67 Million USD | -18211.415% |
| Panbela Therapeutics, Inc. | 25.64 Million USD | -42505.373% |
| CASI Pharmaceuticals, Inc. | 47 Million USD | -23145.969% |
| Cadrenal Therapeutics, Inc. Common Stock | 7.63 Million USD | -143057.667% |
| Centessa Pharmaceuticals plc | 178.13 Million USD | -6034.077% |
| Hepion Pharmaceuticals, Inc. | 48.44 Million USD | -22454.1% |
| Arcturus Therapeutics Holdings Inc. | 245 Million USD | -4359.927% |
| BioRestorative Therapies, Inc. | 15.36 Million USD | -71008.889% |
| Apollomics, Inc. | 54.14 Million USD | -20082.859% |
| Amarin Corporation plc | 272.35 Million USD | -3912.014% |
| Turnstone Biologics Corp. | 78.33 Million USD | -13848.531% |
| Kymera Therapeutics, Inc. | 244.12 Million USD | -4376.041% |
| Synaptogenix, Inc. | 8.31 Million USD | -131331.223% |
| Tiziana Life Sciences Ltd | 14.58 Million USD | -74814.301% |
| Aurinia Pharmaceuticals Inc. | 253.05 Million USD | -4218.017% |
| BriaCell Therapeutics Corp. | 33.33 Million USD | -32684.204% |
| Monopar Therapeutics Inc. | 8.83 Million USD | -123631.279% |
| Exelixis, Inc. | 1.58 Billion USD | -588.629% |
| Better Therapeutics, Inc. | 38.26 Million USD | -28458.361% |
| Nurix Therapeutics, Inc. | 232.05 Million USD | -4608.899% |
| Apellis Pharmaceuticals, Inc. | 855.2 Million USD | -1177.71% |
| NLS Pharmaceutics AG | 11.8 Million USD | -92446.3% |
| Dermata Therapeutics, Inc. | 8.04 Million USD | -135775.749% |
| Aridis Pharmaceuticals, Inc. | 29.99 Million USD | -36331.834% |
| Gritstone bio, Inc. | 148.37 Million USD | -7264.498% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -15768.198% |
| TNF Pharmaceuticals, Inc. | 16.36 Million USD | -66690.064% |
| Avid Bioservices, Inc. | 25.99 Million USD | -41933.39% |
| Insmed Incorporated | 949.26 Million USD | -1051.106% |
| Virpax Pharmaceuticals, Inc. | 15.68 Million USD | -69544.026% |
| MediWound Ltd. | 18.86 Million USD | -57812.868% |
| OmniAb, Inc. | 83.89 Million USD | -12924.614% |
| Alector, Inc. | 248.8 Million USD | -4291.846% |
| Seres Therapeutics, Inc. | 234.3 Million USD | -4563.52% |
| Checkpoint Therapeutics, Inc. | 52.25 Million USD | -20812.518% |
| Zai Lab Limited | 547.47 Million USD | -1895.887% |
| Revance Therapeutics, Inc. | 398.65 Million USD | -2640.973% |
| Aura Biosciences, Inc. | 84.99 Million USD | -12756.655% |
| Lyell Immunopharma, Inc. | 247.13 Million USD | -4321.416% |
| Immunic, Inc. | 99.22 Million USD | -10912.568% |
| Tarsus Pharmaceuticals, Inc. | 159.01 Million USD | -6771.808% |
| Veracyte, Inc. | 357.93 Million USD | -2952.806% |
| InMed Pharmaceuticals Inc. | 9.01 Billion USD | -21.199% |
| FibroGen, Inc. | 398.11 Million USD | -2644.698% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -76796.552% |
| Adial Pharmaceuticals, Inc. | 6.88 Million USD | -158539.432% |
| Sonnet BioTherapeutics Holdings, Inc. | 7.12 Million USD | -153245.649% |
| Jazz Pharmaceuticals plc | 3.25 Billion USD | -235.635% |
| Cyclacel Pharmaceuticals, Inc. | 25.87 Million USD | -42133.216% |
| Amylyx Pharmaceuticals, Inc. | 316.54 Million USD | -3351.98% |
| TG Therapeutics, Inc. | 198.47 Million USD | -5405.479% |
| Galecto, Inc. | 35.62 Million USD | -30570.559% |
| Calithera Biosciences, Inc. | 40.68 Million USD | -26754.924% |
| Fortrea Holdings Inc. | 457.3 Million USD | -2289.46% |
| KalVista Pharmaceuticals, Inc. | 54.27 Million USD | -20031.545% |
| Aptevo Therapeutics Inc. | 28.87 Million USD | -37738.493% |
| XBiotech Inc. | 37.51 Million USD | -29030.898% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -15768.198% |
| Lyra Therapeutics, Inc. | 20.64 Million USD | -52817.817% |
| Foghorn Therapeutics Inc. | 142.06 Million USD | -7591.766% |
| Y-mAbs Therapeutics, Inc. | 99.07 Million USD | -10929.018% |
| Theravance Biopharma, Inc. | 110.71 Million USD | -9769.396% |
| Ultragenyx Pharmaceutical Inc. | 958.24 Million USD | -1040.31% |
| Metagenomi, Inc. Common Stock | 28.84 Million USD | -37781.782% |
| BioCryst Pharmaceuticals, Inc. | 430.64 Million USD | -2437.386% |
| Gain Therapeutics, Inc. | 22.3 Million USD | -48881.741% |
| Cartesian Therapeutics, Inc. | 110.86 Million USD | -9755.954% |
| NexImmune, Inc. | 28.16 Million USD | -38692.921% |
| Creative Medical Technology Holdings, Inc. | 5.53 Million USD | -197461.069% |
| Marker Therapeutics, Inc. | 17.89 Million USD | -60970.243% |
| Regeneron Pharmaceuticals, Inc. | 2.81 Billion USD | -288.129% |
| Chemomab Therapeutics Ltd. | 25.45 Million USD | -42819.989% |
| RAPT Therapeutics, Inc. | 127.06 Million USD | -8499.739% |
| Ainos, Inc. | 12.95 Million USD | -84261.031% |
| Pluri Inc. | 22.48 Million USD | -48507.651% |
| Prothena Corporation plc | 282.4 Million USD | -3769.252% |
| Adaptimmune Therapeutics plc | 200.02 Million USD | -5362.899% |
| Celularity Inc. | 215.05 Million USD | -4980.955% |
| Rallybio Corporation | 78.93 Million USD | -13743.562% |
| Cue Biopharma, Inc. | 19.54 Million USD | -55815.464% |
| MeiraGTx Holdings plc | 151.07 Million USD | -7132.688% |
| Omeros Corporation | 94.75 Million USD | -11432.332% |
| Humacyte, Inc. | 23.49 Million USD | -46403.809% |
| Immunocore Holdings plc | 308.04 Million USD | -3447.267% |
| Cocrystal Pharma, Inc. | 3.39 Million USD | -322230.383% |
| Cidara Therapeutics, Inc. | 86.86 Million USD | -12479.29% |
| Blueprint Medicines Corporation | 722.86 Million USD | -1411.632% |
| CalciMedica, Inc. | 21.81 Million USD | -49984.796% |
| Cabaletta Bio, Inc. | 74.66 Million USD | -14535.682% |
| Scholar Rock Holding Corporation | 171.29 Million USD | -6279.054% |
| Sana Biotechnology, Inc. | 294.94 Million USD | -3604.821% |
| Pulmatrix, Inc. | 22.03 Million USD | -49482.539% |
| Elicio Therapeutics, Inc. | 34.57 Million USD | -31503.76% |
| Vigil Neuroscience, Inc. | 88.86 Million USD | -12196.041% |
| Intellia Therapeutics, Inc. | 551.56 Million USD | -1881.087% |
| Adlai Nortye Ltd. American Depositary Shares | 72.55 Million USD | -14961.129% |
| Cytokinetics, Incorporated | 173.61 Million USD | -6193.92% |
| Eloxx Pharmaceuticals, Inc. | 34.41 Million USD | -31647.0% |
| Nutriband Inc. | 5.73 Million USD | -190464.02% |
| Protara Therapeutics, Inc. | 43.61 Million USD | -24954.456% |
| Vor Biopharma Inc. | 126.03 Million USD | -8569.745% |
| Roivant Sciences Ltd. | 1.18 Billion USD | -818.869% |
| Evogene Ltd. | 27.79 Million USD | -39219.899% |
| ProKidney Corp. | 151.52 Million USD | -7111.494% |
| Applied Therapeutics, Inc. | 74.17 Million USD | -14631.378% |
| BridgeBio Pharma, Inc. | 614.22 Million USD | -1678.984% |
| CorMedix Inc. | 48.95 Million USD | -22219.227% |
| BioLineRx Ltd. | 50.8 Million USD | -21408.996% |
| Tango Therapeutics, Inc. | 150.7 Million USD | -7150.829% |
| Galectin Therapeutics Inc. | 38.07 Million USD | -28600.883% |
| Atai Life Sciences N.V. | 125.78 Million USD | -8587.045% |
| Renovaro Biosciences Inc. | 81.63 Million USD | -13284.486% |
| Aerovate Therapeutics, Inc. | 81.4 Million USD | -13322.349% |
| Zentalis Pharmaceuticals, Inc. | 252.55 Million USD | -4226.634% |
| Sagimet Biosciences Inc. | 32.74 Million USD | -33275.076% |
| MediciNova, Inc. | 10.9 Million USD | -100145.269% |
| Praxis Precision Medicines, Inc. | 128.82 Million USD | -8382.379% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -150419.511% |
| GeoVax Labs, Inc. | 6.02 Million USD | -181346.132% |
| Axsome Therapeutics, Inc. | 476.36 Million USD | -2193.853% |
| Biomea Fusion, Inc. | 126.13 Million USD | -8562.941% |
| PTC Therapeutics, Inc. | 1.31 Billion USD | -732.953% |
| Mereo BioPharma Group plc | 35.84 Million USD | -30386.58% |
| Cullinan Oncology, Inc. | 191.08 Million USD | -5618.278% |
| Absci Corporation | 73.66 Million USD | -14733.166% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -39516.417% |
| 4D Molecular Therapeutics, Inc. | 133.59 Million USD | -8079.504% |
| Dyne Therapeutics, Inc. | 242.16 Million USD | -4412.269% |
| Kiniksa Pharmaceuticals, Ltd. | 262.04 Million USD | -4069.847% |
| Ventyx Biosciences, Inc. | 207.99 Million USD | -5153.517% |
| Allakos Inc. | 196.05 Million USD | -5473.408% |
| Imunon, Inc. | 20.31 Million USD | -53699.957% |
| Fulcrum Therapeutics, Inc. | 113.46 Million USD | -9529.943% |
| Corcept Therapeutics Incorporated | 368.61 Million USD | -2864.364% |
| BioAtla, Inc. | 129.68 Million USD | -8325.671% |
| NLS Pharmaceutics AG | 11.8 Million USD | -92446.3% |
| Bio-Path Holdings, Inc. | 15.84 Million USD | -68870.523% |
| Allogene Therapeutics, Inc. | 84.91 Million USD | -12767.708% |
| Larimar Therapeutics, Inc. | 41.75 Million USD | -26067.441% |
| XOMA Corporation | 46.46 Million USD | -23417.638% |
| Kezar Life Sciences, Inc. | 111.17 Million USD | -9729.002% |
| Cara Therapeutics, Inc. | 142.46 Million USD | -7570.062% |
| aTyr Pharma, Inc. | 12.97 Million USD | -84089.845% |
| Aligos Therapeutics, Inc. | 103.65 Million USD | -10441.599% |
| Akero Therapeutics, Inc. | 172.87 Million USD | -6220.935% |
| Viridian Therapeutics, Inc. | 254.76 Million USD | -4189.068% |
| Eliem Therapeutics, Inc. | 37.4 Million USD | -29110.329% |
| EyeGate Pharmaceuticals, Inc. | 8.22 Million USD | -132754.068% |
| Akari Therapeutics, Plc | 16.8 Million USD | -64918.446% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -480425.249% |
| Halozyme Therapeutics, Inc. | 299.31 Million USD | -3550.632% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -162293.2% |
| UroGen Pharma Ltd. | 138.88 Million USD | -7767.49% |
| Sutro Biopharma, Inc. | 243 Million USD | -4396.541% |
| ZIVO Bioscience, Inc. | 7.27 Million USD | -150107.117% |
| Orgenesis Inc. | 45.75 Million USD | -23780.499% |
| Entera Bio Ltd. | 8.86 Million USD | -123229.571% |
| GH Research PLC | 41.22 Million USD | -26407.69% |
| Lisata Therapeutics, Inc. | 25.7 Million USD | -42404.279% |
| Reneo Pharmaceuticals, Inc. | 83.05 Million USD | -13056.659% |
| Xencor, Inc. | 306.97 Million USD | -3459.55% |
| 60 Degrees Pharmaceuticals, Inc. | 4.93 Million USD | -221381.002% |
| Replimune Group, Inc. | 234.77 Million USD | -4554.283% |
| Coeptis Therapeutics Holdings, Inc. | 20.48 Million USD | -53228.744% |
| Vanda Pharmaceuticals Inc. | 191.79 Million USD | -5597.199% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -162293.2% |
| Portage Biotech Inc. | 18.19 Million USD | -59941.761% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -150419.511% |
| Olema Pharmaceuticals, Inc. | 104.96 Million USD | -10310.533% |
| OncoCyte Corporation | 25.63 Million USD | -42521.992% |
| Qualigen Therapeutics, Inc. | 6.09 Million USD | -179160.244% |
| Processa Pharmaceuticals, Inc. | 11.45 Million USD | -95273.499% |
| Purple Biotech Ltd. | -22.46 Million USD | 48735.777% |
| CollPlant Biotechnologies Ltd. | 16.48 Million USD | -66204.612% |
| scPharmaceuticals Inc. | 65.17 Million USD | -16664.859% |
| ProMIS Neurosciences, Inc. | 8.45 Million USD | -129171.753% |
| HilleVax, Inc. | 133.34 Million USD | -8094.533% |
| NeuroSense Therapeutics Ltd. | 10.28 Million USD | -106142.1% |
| Tharimmune, Inc. | 9.45 Million USD | -115465.793% |
| Genprex, Inc. | 31.06 Million USD | -35079.655% |
| Neumora Therapeutics, Inc. Common Stock | 187.52 Million USD | -5726.925% |
| Atossa Therapeutics, Inc. | 31.37 Million USD | -34724.872% |
| XTL Biopharmaceuticals Ltd. | 765 Thousand USD | -1428266.013% |
| Virios Therapeutics, Inc. | 5.44 Million USD | -200508.821% |
| OKYO Pharma Limited | 8243.57 USD | -132551694.914% |
| Savara Inc. | 15.74 Million USD | -69299.809% |
| Curis, Inc. | 58.35 Million USD | -18625.045% |
| Daré Bioscience, Inc. | 33.6 Million USD | -32411.736% |
| Carmell Therapeutics Corporation | 5.09 Million USD | -214470.952% |
| Titan Pharmaceuticals, Inc. | 7.46 Million USD | -146354.899% |
| Achieve Life Sciences, Inc. | 27.02 Million USD | -40337.421% |
| BeiGene, Ltd. | 3.28 Billion USD | -232.472% |
| Kiromic BioPharma, Inc. | 19.93 Million USD | -54701.322% |
| Revolution Medicines, Inc. Warrant | 498.76 Million USD | -2090.811% |
| Protagonist Therapeutics, Inc. | 153.65 Million USD | -7011.525% |
| Erasca, Inc. | 141.52 Million USD | -7620.897% |
| bluebird bio, Inc. | 240.23 Million USD | -4448.52% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -241275.365% |
| BioMarin Pharmaceutical Inc. | 1.74 Billion USD | -525.732% |
| DBV Technologies S.A. | 92.16 Million USD | -11756.554% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -241275.365% |
| Moderna, Inc. | 6.39 Billion USD | -70.895% |
| Vincerx Pharma, Inc. | 42.6 Million USD | -25544.817% |
| Fresh Tracks Therapeutics, Inc. | 14.36 Million USD | -75961.534% |
| Acrivon Therapeutics, Inc. Common Stock | 66.7 Million USD | -16282.063% |
| Travere Therapeutics, Inc. | 472 Million USD | -2215.033% |
| Monte Rosa Therapeutics, Inc. | 143.31 Million USD | -7524.676% |
| Spruce Biosciences, Inc. | 62.08 Million USD | -17500.915% |
| Celldex Therapeutics, Inc. | 43.41 Million USD | -25069.3% |
| Cogent Biosciences, Inc. | 208.13 Million USD | -5150.084% |
| MacroGenics, Inc. | 217.21 Million USD | -4930.5% |
| RenovoRx, Inc. | 11.39 Million USD | -95784.521% |
| Adicet Bio, Inc. | 152.03 Million USD | -7087.019% |
| Prime Medicine, Inc. | 186.63 Million USD | -5754.618% |
| Aditxt, Inc. | 25.95 Million USD | -42006.659% |
| Adagene Inc. | 41.83 Million USD | -26021.553% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -149378.16% |
| Quantum-Si incorporated | 111.65 Million USD | -9686.045% |
| Maravai LifeSciences Holdings, Inc. | 171.85 Million USD | -6258.452% |
| Acurx Pharmaceuticals, Inc. | 14.57 Million USD | -74856.605% |
| Voyager Therapeutics, Inc. | 35.82 Million USD | -30403.601% |
| SciSparc Ltd. | 9.01 Million USD | -121162.901% |
| Vericel Corporation | 142.04 Million USD | -7592.903% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -126126.454% |
| Minerva Neurosciences, Inc. | 23.08 Million USD | -47226.398% |
| Generation Bio Co. | 144.46 Million USD | -7463.665% |
| Astria Therapeutics, Inc. | 83.03 Million USD | -13060.304% |
| Black Diamond Therapeutics, Inc. | 86.46 Million USD | -12538.214% |
| Arcutis Biotherapeutics, Inc. | 295.72 Million USD | -3595.049% |
| Invivyd, Inc. | 205.75 Million USD | -5210.685% |
| Relay Therapeutics, Inc. | 72.15 Million USD | -15042.948% |
| Quoin Pharmaceuticals, Ltd. | 9.37 Million USD | -116411.119% |
| Spero Therapeutics, Inc. | 75.25 Million USD | -14420.158% |
| Artelo Biosciences, Inc. | 10.28 Million USD | -106121.445% |
| 2seventy bio, Inc. | 289.88 Million USD | -3669.4% |
| Clene Inc. | 41.07 Million USD | -26503.852% |
| Capricor Therapeutics, Inc. | 12.8 Million USD | -85214.626% |
| Boundless Bio, Inc. Common Stock | 54.79 Million USD | -19841.237% |
| GeoVax Labs, Inc. | 6.02 Million USD | -181346.132% |
| Recursion Pharmaceuticals, Inc. | 352.04 Million USD | -3003.838% |
| Citius Pharmaceuticals, Inc. | 36.73 Million USD | -29647.889% |
| Contineum Therapeutics, Inc. Class A Common Stock | 33.72 Million USD | -32297.415% |
| Relmada Therapeutics, Inc. | 103.7 Million USD | -10436.923% |
| Finch Therapeutics Group, Inc. | 32.58 Million USD | -33429.719% |
| ALX Oncology Holdings Inc. | 170.27 Million USD | -6317.153% |
| Vir Biotechnology, Inc. | 767.72 Million USD | -1323.305% |
| Evaxion Biotech A/S | 22.27 Million USD | -48966.008% |
| Ocular Therapeutix, Inc. | 135.54 Million USD | -7961.589% |
| Verve Therapeutics, Inc. | 234.88 Million USD | -4552.123% |
| Trevena, Inc. | 38.41 Million USD | -28346.099% |
| Surrozen, Inc. | 18.55 Million USD | -58805.66% |
| Tyra Biosciences, Inc. | 79.94 Million USD | -13568.147% |
| Cingulate Inc. | 22.75 Million USD | -47911.377% |
| Galmed Pharmaceuticals Ltd. | -7.49 Million USD | 145948.905% |
| Unity Biotechnology, Inc. | 44.66 Million USD | -24363.25% |
| Tenax Therapeutics, Inc. | 8.23 Million USD | -132606.805% |
| Terns Pharmaceuticals, Inc. | 102.55 Million USD | -10554.459% |
| ACADIA Pharmaceuticals Inc. | 754.08 Million USD | -1349.041% |
| Connect Biopharma Holdings Limited | 62.07 Million USD | -17503.183% |
| Clearmind Medicine Inc. | 8.74 Million USD | -124903.575% |
| Kronos Bio, Inc. | 128.11 Million USD | -8428.856% |
| Bolt Biotherapeutics, Inc. | 84.07 Million USD | -12897.193% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -372455.605% |
| Viking Therapeutics, Inc. | 100.82 Million USD | -10737.375% |
| Statera Biopharma, Inc. | 28.82 Million USD | -37802.141% |
| ImmunityBio, Inc. | 362.87 Million USD | -2911.255% |
| Korro Bio, Inc. | 84.53 Million USD | -12826.16% |
| Kineta, Inc. | 21.15 Million USD | -51549.65% |
| BioVie Inc. | 31.95 Million USD | -34100.09% |
| Codexis, Inc. | 66.51 Million USD | -16327.133% |
| Celularity Inc. | 215.05 Million USD | -4980.955% |
| Crinetics Pharmaceuticals, Inc. | 226.62 Million USD | -4721.707% |
| Celcuity Inc. | 66.23 Million USD | -16398.483% |
| Virax Biolabs Group Limited | 6.54 Million USD | -166799.265% |
| Cibus, Inc. | 320.3 Million USD | -3311.436% |
| Eledon Pharmaceuticals, Inc. | 43 Million USD | -25311.628% |
| IN8bio, Inc. | 30.33 Million USD | -35918.723% |
| Kodiak Sciences Inc. | 277.32 Million USD | -3840.199% |
| Annexon, Inc. | 143.72 Million USD | -7502.819% |
| Adverum Biotechnologies, Inc. | 127.59 Million USD | -8464.084% |
| Assembly Biosciences, Inc. | 22.9 Million USD | -47597.411% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -1707243.75% |
| Ionis Pharmaceuticals, Inc. | 779.58 Million USD | -1301.64% |
| Eyenovia, Inc. | 25.4 Million USD | -42908.77% |
| Puma Biotechnology, Inc. | 140.31 Million USD | -7687.478% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -196358.109% |
| Xilio Therapeutics, Inc. | 79.13 Million USD | -13708.399% |
| Arcellx, Inc. | 200.19 Million USD | -5358.069% |
| Cardiff Oncology, Inc. | 45.9 Million USD | -23706.1% |
| Enanta Pharmaceuticals, Inc. | 216.41 Million USD | -4949.189% |
| Regulus Therapeutics Inc. | 9.95 Million USD | -109641.89% |
| Moolec Science SA | 52.75 Million USD | -20614.454% |
| Acumen Pharmaceuticals, Inc. | 61.13 Million USD | -17772.681% |
| LAVA Therapeutics N.V. | 46.54 Million USD | -23378.728% |
| Royalty Pharma plc | 862.4 Million USD | -1167.04% |
| Atea Pharmaceuticals, Inc. | 94.07 Million USD | -11515.571% |
| Greenwich LifeSciences, Inc. | 9.32 Million USD | -117043.621% |
| TFF Pharmaceuticals, Inc. | 22.62 Million USD | -48188.592% |
| Mersana Therapeutics, Inc. | 207.81 Million USD | -5158.118% |
| Humacyte, Inc. | 23.49 Million USD | -46403.809% |
| 89bio, Inc. | 151.2 Million USD | -7126.661% |
| PMV Pharmaceuticals, Inc. | 80.13 Million USD | -13536.25% |
| Avenue Therapeutics, Inc. | 14.54 Million USD | -75051.307% |
| Genelux Corporation | 24.33 Million USD | -44802.404% |
| Trevi Therapeutics, Inc. | 33.92 Million USD | -32111.184% |
| Lexicon Pharmaceuticals, Inc. | 172.86 Million USD | -6220.971% |
| Notable Labs, Ltd. | 14.77 Million USD | -73881.043% |
| Liquidia Corporation | 87.98 Million USD | -12319.304% |
| Mustang Bio, Inc. | 48.5 Million USD | -22429.432% |
| Immunovant, Inc. | 282.7 Million USD | -3765.105% |
| Quantum-Si incorporated | 111.65 Million USD | -9686.045% |
| Arbutus Biopharma Corporation | 22.54 Million USD | -48369.659% |
| DiaMedica Therapeutics Inc. | 21.26 Million USD | -51280.072% |
| Vera Therapeutics, Inc. | 102.01 Million USD | -10611.485% |
| Acasti Pharma Inc. | 11.3 Million USD | -96590.558% |
| MiNK Therapeutics, Inc. | 22.92 Million USD | -47572.222% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -68281.958% |
| Xenon Pharmaceuticals Inc. | 46.54 Million USD | -23377.719% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -962987.662% |
| NeuroBo Pharmaceuticals, Inc. | 15.88 Million USD | -68683.835% |
| Tempest Therapeutics, Inc. | 29.15 Million USD | -37376.421% |
| Soleno Therapeutics, Inc. | 41.38 Million USD | -26303.924% |
| PepGen Inc. | 84.76 Million USD | -12790.782% |
| Moleculin Biotech, Inc. | 29.63 Million USD | -36776.919% |
| United Therapeutics Corporation | 885.1 Million USD | -1134.55% |
| Nuvectis Pharma, Inc. | 22.89 Million USD | -47622.409% |
| Solid Biosciences Inc. | 104.31 Million USD | -10375.004% |
| BriaCell Therapeutics Corp. | 32.72 Million USD | -33289.829% |
| Immuneering Corporation | 58.41 Million USD | -18606.489% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -214565.882% |
| Silo Pharma, Inc. | 3.92 Million USD | -278518.083% |
| Belite Bio, Inc | 31.66 Million USD | -34404.863% |
| XOMA Corporation | 46.46 Million USD | -23417.638% |
| ARS Pharmaceuticals, Inc. | 67.55 Million USD | -16076.166% |
| Bionomics Limited | 17.89 Billion USD | 38.929% |
| Apogee Therapeutics, Inc. | 93 Million USD | -11649.083% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 30725.0% |
| uniQure N.V. | 285.08 Million USD | -3732.878% |
| Cassava Sciences, Inc. | 105.95 Million USD | -10212.674% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -149378.16% |
| Poseida Therapeutics, Inc. | 194.2 Million USD | -5526.471% |
| Forte Biosciences, Inc. | 32.47 Million USD | -33545.35% |
| Anebulo Pharmaceuticals, Inc. | 8.3 Million USD | -131411.881% |
| Enlivex Therapeutics Ltd. | 29.39 Million USD | -37072.989% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -196358.109% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -76796.552% |
| FibroBiologics, Inc. Common Stock | 8.88 Million USD | -122827.213% |
| Altimmune, Inc. | 30.55 Million USD | -35660.571% |
| Amicus Therapeutics, Inc. | 427.65 Million USD | -2455.121% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 30725.0% |
| Compugen Ltd. | 43.97 Million USD | -24750.47% |
| Peak Bio, Inc. | 1249.13 USD | -874768739.112% |
| Zevra Therapeutics, Inc. | 74.12 Million USD | -14642.31% |
| Benitec Biopharma Inc. | 22.38 Million USD | -48720.481% |
| Spyre Therapeutics, Inc. | 243.18 Million USD | -4393.213% |
| NKGen Biotech, Inc. Common Stock | 28.54 Million USD | -38182.591% |
| Zura Bio Limited | 62.63 Million USD | -17344.682% |
| PolyPid Ltd. | 21.04 Million USD | -51822.072% |
| Aileron Therapeutics, Inc. | 16.27 Million USD | -67035.66% |
| NKGen Biotech, Inc. Warrants | 28.54 Million USD | -38182.591% |
| Instil Bio, Inc. | 85.78 Million USD | -12637.658% |
| argenx SE | 1.53 Billion USD | -612.539% |
| Immunome, Inc. | 122.82 Million USD | -8796.759% |
| Verona Pharma plc | 67.15 Million USD | -16172.215% |
| enGene Holdings Inc. Warrants | 25.88 Million USD | -42113.637% |
| Shattuck Labs, Inc. | 93.61 Million USD | -11572.399% |
| CervoMed Inc. | 14.95 Million USD | -72952.348% |
| LENZ Therapeutics, Inc. | 70.7 Million USD | -15354.79% |
| Plus Therapeutics, Inc. | 8.54 Million USD | -127790.918% |
| Dianthus Therapeutics, Inc. | 51 Million USD | -21325.49% |
| Moolec Science SA | 52.75 Million USD | -20614.454% |
| Enveric Biosciences, Inc. | 16.44 Million USD | -66331.832% |
| Inovio Pharmaceuticals, Inc. | 132.55 Million USD | -8143.363% |
| Design Therapeutics, Inc. | 78.19 Million USD | -13874.933% |
| Leap Therapeutics, Inc. | 87.04 Million USD | -12453.854% |
| NeurAxis, Inc. | 8.82 Million USD | -123772.05% |
| Seelos Therapeutics, Inc. | 12.58 Million USD | -86725.586% |
| Lumos Pharma, Inc. | 38.66 Million USD | -28160.701% |
| Achilles Therapeutics plc | 75.25 Million USD | -14419.965% |
| enGene Holdings Inc. Common Stock | 25.88 Million USD | -42113.637% |
| 180 Life Sciences Corp. | 13.47 Million USD | -80975.867% |
| Opiant Pharmaceuticals, Inc. | 26.5 Million USD | -41130.163% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -372455.605% |
| Nutriband Inc. | 5.73 Million USD | -190464.02% |
| ORIC Pharmaceuticals, Inc. | 110.78 Million USD | -9763.694% |
| CG Oncology, Inc. Common stock | 55.65 Million USD | -19534.162% |
| Fractyl Health, Inc. Common Stock | 50.87 Million USD | -21376.444% |
| Rani Therapeutics Holdings, Inc. | 66.09 Million USD | -16431.264% |
| MoonLake Immunotherapeutics | 54.12 Million USD | -20089.163% |
| Palisade Bio, Inc. | 13.32 Million USD | -81934.535% |
| Tourmaline Bio, Inc. | 45.4 Million USD | -23963.512% |
| Beam Therapeutics Inc. | 554.19 Million USD | -1871.692% |
| Neurogene Inc. | 55.58 Million USD | -19558.889% |
| Mirum Pharmaceuticals, Inc. | 248.48 Million USD | -4297.378% |
| AEON Biopharma, Inc. | 48.42 Million USD | -22462.927% |
| Sesen Bio, Inc. | 78.38 Million USD | -13840.879% |
| Enliven Therapeutics, Inc. | 83.52 Million USD | -12981.684% |
| Kiora Pharmaceuticals, Inc. | 12.58 Million USD | -86712.507% |
| Iovance Biotherapeutics, Inc. | 450.99 Million USD | -2322.876% |
| Taysha Gene Therapies, Inc. | 87.89 Million USD | -12332.586% |
| Athira Pharma, Inc. | 125.46 Million USD | -8609.132% |
| Vaccinex, Inc. | 23.45 Million USD | -46487.082% |
| HCW Biologics Inc. | 21.02 Million USD | -51865.234% |
| XOMA Corporation | 46.46 Million USD | -23417.638% |
| Nektar Therapeutics | 190.9 Million USD | -5623.849% |
| Arvinas, Inc. | 480 Million USD | -2176.458% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -480425.249% |
| Merus N.V. | 200.49 Million USD | -5350.038% |
| Omega Therapeutics, Inc. | 103.35 Million USD | -10472.299% |
| Quince Therapeutics, Inc. | 34.62 Million USD | -31462.681% |
| Rezolute, Inc. | 70.38 Million USD | -15424.173% |
| Clene Inc. | 41.07 Million USD | -26503.852% |
| Indaptus Therapeutics, Inc. | 16.37 Million USD | -66615.617% |
| BeyondSpring Inc. | 24.86 Million USD | -43845.305% |
| Synlogic, Inc. | 58.53 Million USD | -18568.421% |
| Allarity Therapeutics, Inc. | 17.89 Million USD | -60971.987% |
| Phio Pharmaceuticals Corp. | 4.49 Million USD | -243154.675% |
| Peak Bio, Inc. | 1249.13 USD | -874768739.112% |
| Werewolf Therapeutics, Inc. | 60.44 Million USD | -17977.292% |
| Krystal Biotech, Inc. | 160.42 Million USD | -6711.24% |
| Karyopharm Therapeutics Inc. | 270.63 Million USD | -3937.601% |
| SpringWorks Therapeutics, Inc. | 348.03 Million USD | -3039.6% |
| Lipella Pharmaceuticals Inc. | 2.15 Million USD | -506545.697% |
| MannKind Corporation | 125.59 Million USD | -8600.049% |
| Ikena Oncology, Inc. | 84.57 Million USD | -12819.588% |
| Cyclerion Therapeutics, Inc. | 9.64 Million USD | -113168.374% |
| Gyre Therapeutics, Inc. | 89.6 Million USD | -12095.176% |
| Gossamer Bio, Inc. | 183.75 Million USD | -5846.375% |
| CohBar, Inc. | 12.38 Million USD | -88104.214% |
| Cognition Therapeutics, Inc. | 50.72 Million USD | -21442.071% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -39516.417% |
| Legend Biotech Corporation | 583.14 Million USD | -1773.805% |
| Mural Oncology plc | 192.07 Million USD | -5589.042% |
| Biora Therapeutics, Inc. | 67.14 Million USD | -16173.251% |
| PaxMedica, Inc. Common Stock | 16.14 Million USD | -67579.26% |
| Disc Medicine, Inc. | 91.12 Million USD | -11891.221% |
| Champions Oncology, Inc. | 28.11 Million USD | -38772.287% |
| REGENXBIO Inc. | 321.15 Million USD | -3302.386% |
| Ensysce Biosciences, Inc. | 5.36 Million USD | -203715.017% |
| Anavex Life Sciences Corp. | 55.75 Million USD | -19497.891% |
| Cellectar Biosciences, Inc. | 38.96 Million USD | -27946.252% |
| Edgewise Therapeutics, Inc. | 114.35 Million USD | -9455.165% |
| Vaxart, Inc. | 90.72 Million USD | -11943.957% |
| PharmaCyte Biotech, Inc. | 8.52 Million USD | -128151.053% |
| Aldeyra Therapeutics, Inc. | 42.79 Million USD | -25433.904% |
| Cellectis S.A. | 97.32 Million USD | -11127.908% |
| Longeveron Inc. | 21.25 Million USD | -51321.176% |
| Repare Therapeutics Inc. | 167.35 Million USD | -6429.156% |
| Sarepta Therapeutics, Inc. | 1.36 Billion USD | -702.974% |
| Inozyme Pharma, Inc. | 75.64 Million USD | -14345.105% |
| Revolution Medicines, Inc. | 498.76 Million USD | -2090.811% |
| Nymox Pharmaceutical Corporation | 6.65 Million USD | -164166.386% |
| Third Harmonic Bio, Inc. | 43.95 Million USD | -24760.081% |
| ArriVent BioPharma, Inc. Common Stock | 74.59 Million USD | -14549.417% |
| AN2 Therapeutics, Inc. | 69.63 Million USD | -15591.822% |
| Anixa Biosciences, Inc. | 11.06 Million USD | -98697.468% |
| Vertex Pharmaceuticals Incorporated | 4.77 Billion USD | -128.838% |
| Denali Therapeutics Inc. | 527.23 Million USD | -1972.53% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -126126.454% |
| Veru Inc. | 101.34 Million USD | -10681.648% |
| Corvus Pharmaceuticals, Inc. | 23.4 Million USD | -46582.616% |
| Cingulate Inc. | 22.75 Million USD | -47911.377% |
| Passage Bio, Inc. | 108.38 Million USD | -9981.281% |
| Context Therapeutics Inc. | 25.07 Million USD | -43481.412% |
| Exicure, Inc. | 14.07 Million USD | -77528.588% |
| Day One Biopharmaceuticals, Inc. | 206.06 Million USD | -5202.721% |
| Oramed Pharmaceuticals Inc. | 43.3 Million USD | -25134.983% |
| Scinai Immunotherapeutics Ltd. | 9.17 Million USD | -118965.65% |
| Rhythm Pharmaceuticals, Inc. | 252.48 Million USD | -4227.816% |
| Nuvalent, Inc. | 149.49 Million USD | -7209.421% |
| ABVC BioPharma, Inc. | 8.06 Million USD | -135354.726% |
| Carisma Therapeutics, Inc. | 103.65 Million USD | -10442.209% |
| Unicycive Therapeutics, Inc. | 21.44 Million USD | -50844.1% |
| OmniAb, Inc. | 83.89 Million USD | -12924.614% |
| Anew Medical, Inc. | 1.3 Million USD | -839895.049% |
| Fennec Pharmaceuticals Inc. | 32.76 Million USD | -33250.629% |
| Lipocine Inc. | 15.08 Million USD | -72359.544% |
| Lexeo Therapeutics, Inc. Common Stock | 68.51 Million USD | -15848.798% |
| Nautilus Biotechnology, Inc. | 76.15 Million USD | -14248.934% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -27004.519% |
| G1 Therapeutics, Inc. | 114.84 Million USD | -9414.729% |
| Bellerophon Therapeutics, Inc. | 22.38 Million USD | -48716.119% |
| Sage Therapeutics, Inc. | 664.14 Million USD | -1545.273% |
| Ocugen, Inc. | 71.56 Million USD | -15168.21% |
| Mind Medicine (MindMed) Inc. | 93.86 Million USD | -11541.063% |
| Q32 Bio Inc. | 92.68 Million USD | -11690.03% |
| Brainstorm Cell Therapeutics Inc. | 21.17 Million USD | -51505.743% |
| Alumis Inc. Common Stock | 158.17 Million USD | -6808.215% |
| Equillium, Inc. | 50.6 Million USD | -21492.301% |
| Kyverna Therapeutics, Inc. | 62.4 Million USD | -17409.534% |
| Coya Therapeutics, Inc. | 13.9 Million USD | -78480.107% |
| CNS Pharmaceuticals, Inc. | 18.86 Million USD | -57821.746% |
| Galera Therapeutics, Inc. | 46.95 Million USD | -23173.2% |
| Evelo Biosciences, Inc. | 108.46 Million USD | -9974.125% |
| Comera Life Sciences Holdings, Inc. | 12.39 Million USD | -88072.684% |
| Dominari Holdings Inc. | 23.83 Million USD | -45744.347% |
| Edesa Biotech, Inc. | 9.22 Million USD | -118378.659% |
| vTv Therapeutics Inc. | 11.9 Million USD | -91669.547% |
| Bio-Techne Corporation | 563.03 Million USD | -1840.718% |
| Agios Pharmaceuticals, Inc. | 408.8 Million USD | -2572.906% |
| Harmony Biosciences Holdings, Inc. | 268.75 Million USD | -3965.77% |
| Prelude Therapeutics Incorporated | 132.27 Million USD | -8160.695% |
| Candel Therapeutics, Inc. | 14.41 Million USD | -75724.023% |
| iTeos Therapeutics, Inc. | 163.69 Million USD | -6575.178% |
| Nkarta, Inc. | 131.65 Million USD | -8200.038% |
| BioCardia, Inc. | 12.12 Million USD | -90049.328% |
| Iterum Therapeutics plc | 47.46 Million USD | -22919.719% |